About
Personalized Cancer T cell Therapies targeting neoantigens
Areas of Focus
Categories
Stem Cell & Cellular Therapy
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
41
By Phase
PHASE2: 1PHASE1/PHASE2: 2
By Status
TERMINATED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT04785365Lead Sponsor
Long-Term Follow-Up Study of Patients Receiving ATL001
PHASE2Terminated
1 participants
Started: Jun 1, 2022 · Completed: Oct 18, 2023
NCT03997474Lead Sponsor
ATL001 in Patients With Metastatic or Recurrent Melanoma
PHASE1/PHASE2Terminated
13 participants
Started: Aug 15, 2019 · Completed: Sep 3, 2024
NCT04032847Lead Sponsor
ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC
PHASE1/PHASE2Terminated
27 participants
Started: Jul 8, 2019 · Completed: Sep 26, 2024
Locations (1)
Headquarters
London, UK
Map
Loading map...